Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Paclitaxel and Platinum in Advanced Cervical Cancer
NCT05735145Phase 3Recruiting
- Sponsor
- Fourth Affiliated Hospital of Guangxi Medical University
- Start
- Jul 2022
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel in Uterine Cervical Neoplasms, sponsored by Fourth Affiliated Hospital of Guangxi Medical University. Started Jul 2022; status: recruiting.
02
Drugs
paclitaxel
03
Conditions
Uterine Cervical Neoplasms
Beyond the preview
Go deeper on NCT05735145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05735145.